Akebia Therapeutics Inc
For the period ended Mar 31, 2024. Filed May 9, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2024 · Filed May 9, 2024
AKBA$0.53+32.8%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 6. Exhibits
| Exhibits | |
|---|---|
| 3.1 | Ninth Amended and Restated Certificate of Incorporation (incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K (001-36352), filed on March 28, 2014). |
| 3.2 | Certificate of Amendment of Ninth Amended and Restated Certificate of Incorporation of Akebia Therapeutics, Inc. (incorporated by reference to Exhibit 3.1 to the Company's Current Report on Form 8-K (001-36352), filed on June 9, 2020). |
| 3.3 | Second Amended and Restated Bylaws (incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K (001-36352), filed on April 28, 2023). |
| 4.1 | Form of Warrant (incorporated by reference to Exhibit 4.7 to the Company’s Annual Report on Form 10-K (001-36352), filed March 14,2024). |
| 10.1† | Third Amended and Restated Non-Employee Director Compensation Program, effective January 1, 2024 (incorporated by reference to Exhibit 10.21 to the Company’s Annual Report on Form 10-K (001-36352), filed on March 14, 2024). |
| 10.2† | Form of Officer Executive Severance Agreement (Reflecting Clawback Policy) (incorporated by reference to Exhibit 10.43 to the Company’s Annual Report on Form 10-K (001-36352), filed on March 14, 2024). |
| 10.3† | Form of Officer Cash Bonus Agreement (Reflecting Clawback Policy) (incorporated by reference to Exhibit 10.44 to the Company’s Annual Report on Form 10-K (001-36352), filed on March 14, 2024). |
| 10.4† | Form of Officer Stock Option Agreement under 2023 Stock Incentive Plan (Reflecting Clawback Policy) (incorporated by reference to Exhibit 10.45 to the Company’s Annual Report on Form 10-K (001-36352), filed on March 14, 2024). |
| 10.5† | Form of Officer Restricted Stock Unit Agreement under 2023 Stock Incentive Plan (Reflecting Clawback Policy) (incorporated by reference to Exhibit 10.46 to the Company’s Annual Report on Form 10-K (001-36352), filed on March 14, 2024). |
| 10.6† | Form of Officer Inducement Award Stock Option Agreement under 2023 Stock Incentive Plan (Reflecting Clawback Policy) (incorporated by reference to Exhibit 10.47 to the Company’s Annual Report on Form 10-K (001-36352), filed on March 14, 2024). |
| 10.7†! | February 2024 Amendment to Retention and Separation Agreement for Nicole R. Hadas (incorporated by reference to Exhibit 10.66 to the Company’s Annual Report on Form 10-K (001-36352), filed on March 14, 2024). |
| 10.8†! | February 2024 Amendment to Retention and Separation Agreement for Michel Dahan (incorporated by reference to Exhibit 10.67 to the Company’s Annual Report on Form 10-K (001-36352), filed on March 14, 2024). |
| 10.9! | Agreement for the Provision of a Loan Facility dated January 29, 2024 between the Company and Kreos Capital VII (UK) Limited (incorporated by reference to Exhibit 10.102 to the Company’s Annual Report on Form 10-K (001-36352), filed on March 14, 2024). |
| 10.10 | Warrant Agreement dated January 29, 2024 by and between the Company and Kreos Capital VII Aggregator SCSp (incorporated by reference to Exhibit 10.103 to the Company’s Annual Report on Form 10-K (001-36352), filed on March 14, 2024). |
| 10.11*† | Separation Agreement with Ellen Snow, dated March 15, 2024. |
| 31.1* | Certification of Principal Executive Officer Required Under Rule 13a-14(a) of the Securities Exchange Act of 1934, as amended. |
|---|---|
| 32.1* | Certification of Principal Executive Officer and Interim Principal Financial Officer Required Under Rule 13a-14(a)/Rule 15d-14(a) of the Securities Exchange Act of 1934, as amended. |
| 101.INS* | Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because XBRL tags are embedded within the Inline XBRL document) |
| 101.SCH* | Inline XBRL Taxonomy Extension Schema Document |
| 101.CAL* | Inline XBRL Taxonomy Extension Calculation Linkbase Document |
| 101.DEF* | Inline XBRL Taxonomy Extension Definition Linkbase Document |
| 101.LAB* | Inline XBRL Taxonomy Extension Labels Linkbase Document |
| 101.PRE* | Inline XBRL Taxonomy Extension Presentation Linkbase Document |
| 104* | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) |
- Filed, or submitted electronically, herewith
! Indicates portions of the exhibit (indicated by asterisks) have been omitted pursuant to Item 601(b)(10)(iv) of Regulation S-K
† Indicates management contract or compensatory plan
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.